Mint Tower Capital Management’s Gilead Sciences GILD Stock Holding History

Mint Tower Capital Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-22,500	Closed	-$1.93M	–	318
2022 Q4	$1.93M	Buy	+22,500	New	+$1.78M	0.17%	111
2022 Q3	–	Sell	-35,900	Closed	-$2.22M	–	484
2022 Q2	$2.22M	Sell	35,900 -10,100	-22%	-$625K	0.18%	112
2022 Q1	$2.73M	Buy	46,000 +44,000	+2,200%	+$2.81M	0.25%	71
2021 Q4	$145K	Buy	+2,000	New	+$138K	0.02%	294
2020 Q1	–	Sell	-133,700	Closed	-$8.69M	–	252
2019 Q4	$8.69M	Buy	133,700 +41,600	+45%	+$2.71M	1.15%	15
2019 Q3	$5.84M	Sell	92,100 -12,700	-12%	-$830K	0.85%	19
2019 Q2	$7.08M	Sell	104,800 -10,500	-9%	-$691K	0.77%	25
2019 Q1	$7.5M	Buy	115,300 +115,250	+230,500%	+$7.66M	0.72%	22
2018 Q4	$313K	Sell	50 -71,450	-100%	-$4.99M	0.04%	148
2018 Q3	$5.52M	Sell	71,500 -47,500	-40%	-$3.59M	0.68%	27
2018 Q2	$8.43M	Hold	119,000	–	–	1.13%	16
2018 Q1	$8.97M	Buy	119,000 +118,785	+55,249%	+$9.44M	1.2%	10
2017 Q4	$1.54M	Buy	+215	New	+$16.3K	0.23%	56

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Mint Tower Capital Management's GILD Position: Q1 2023 in Review

Mint Tower Capital Management sold out of Gilead Sciences (GILD) in Q1 2023, closing a stake of 5,004 shares — an estimated $430K sold.

Mint Tower Capital Management first reported a position in GILD in Q4 2017 and held it in 7 quarters. The position peaked at $2.19M in Q4 2019. 1,735 funds tracked by Wall St. Rank hold GILD as of Q1 2023.

Mint Tower Capital Management reported no remaining Gilead Sciences position as of Q1 2023 after selling out during the quarter.
Mint Tower Capital Management sold 5,004 Gilead Sciences shares in Q1 2023, an estimated $430K.
Mint Tower Capital Management first reported a position in Gilead Sciences in Q4 2017 and held it in 7 quarters.
Mint Tower Capital Management's Gilead Sciences position peaked at $2.19M in Q4 2019.
1,735 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2023.

Based on Mint Tower Capital Management's 13F filing for Q1 2023, filed 9 May 2023.